Available Until 10/29/2022

Pharmacy Perspectives: Optimizing Treatment of Idiopathic Multicentric Castleman Disease

Please note: your participation will not show as ‘Completed’ on ASHP’s website.  

Your statement of participation will be saved on the Paradigm Medical Communications LLC website.  

This webinar will include a review of the pathophysiology of iMCD and how it applies to the development of current and emerging treatments. The expert faculty will discuss clinical trial data for current and emerging therapies, with a focus on efficacy, safety, appropriate dosing and formulations, drug-drug interactions, and pandemic-related considerations. Case studies will illustrate how pharmacists can apply evidence-based guideline recommendations to develop patient treatment plans. 

Please note: The content for this activity is hosted on another CE Provider’s site.


Any CPE credit earned for this activity will be reported to CPE Monitor by Educational Review Systems. Questions/Comments concerning this activity should be directed to amcmorrow@paradigmmc.com.